- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05210816
Acceptance and Commitment Therapy (ACT) in Early Psychosis Patients
The Effect of Acceptance and Commitment Therapy on Psychotic Symptoms and Functioning Levels in Early Psychosis Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
This study is a pretest, posttest, follow-up, randomized controlled experimental study. This study will be conducted at the Health Sciences University Sultan II. Abdulhamid Han Training and Research Hospital, Department of Psychiatry. According to the G-power analysis results, the minimum sample size of the study was calculated as 40 (intervention 20, control 20). Before randomization, the Personal Information Form and P1-P3 questions on the Positive and Negative Syndrome Scale (PANNS) will be applied to the patients in order to identify the patients with early psychosis. Computer-aided https://www.random.org/integers/ program will be used to assign the intervention and control group without bias. It is planned that the intervention group will consist of at least 8 participants and the program will be implemented as three intervention groups. Acceptance and Commitment Therapy (ACT) Based Intervention Program was applied to the intervention group in eight sessions online. Each session will last an average of 60-90 minutes. There will be two sessions for one group per week. The control group will not receive any intervention by the researcher, and participants will continue with their routine treatment plan. The intervention groups after the program is completed and three months later, follow-up will be done by applying the post-test, while the control group will be followed-up by applying the post-test four weeks and three months later.
In the preparation of the interventions and planning of the sessions based on ACT, the researcher utilised studies in the literature and the basic ACT training she had received. After preparation of the ACT intervention protocol, it was given its final shape by obtaining the views of specialists working in this field. The sessions were prepared based on six components of psychological flexibility found at the basis of ACT.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Duygu ÖZER, MsN
- Phone Number: +90 5061291978
- Email: duyguozer2016@hotmail.com
Study Contact Backup
- Name: Melike DİŞSİZ, Assoc. Prof.
- Phone Number: +90 5437995143
- Email: melike.dişsiz@sbu.edu.tr
Study Locations
-
-
-
Istanbul, Turkey, 34668
- Recruiting
- Saglik Bilimleri Universitesi
-
Contact:
- Duygu ÖZER, MsN
- Phone Number: +90 5061291978
- Email: duyguozer2016@hotmail.com
-
Sub-Investigator:
- Melike Dişsiz, Assoc. Prof.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The consent of himself/herself or his/she guardian to participate in the research,
- Being diagnosed with schizophrenia and other psychotic disorders for a minimum of six months and a maximum of three years according to DSM-V diagnostic criteria,
- Not to be in the acute attack period of the disease,
- The home environment is suitable for online conversation (computer/smartphone, internet at home, the patient can be alone in the room during the session, etc.)
- Being between the ages of 18-65,
- Ability to read and write,
- There is no communication problem at a level that prevents the conversation,
- Absence of mental retardation, neurocognitive disorder, alcohol and substance abuse
Exclusion Criteria:
- Her/his is or her/his is guardian's refusal to participate in the research,
- Being diagnosed with schizophrenia and other psychotic disorders for less than six months or for more than three years, according to DSM-V diagnostic criteria,
- Being in the acute attack period of the disease,
- Not being able to read and write,
- Having a communication problem at a level that prevents the conversation,
- Having mental retardation, neurocognitive disorder, alcohol and substance addiction
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ACT
''Acceptance and Commitment Therapy (ACT) Based Intervention Program was applied to the intervention group.
|
Acceptance and Commitment Therapy Based Intervention Program was applied to the intervention group in eight sessions online.
Each session will last an average of 60-90 minutes.
There will be two sessions for one group per week.
|
No Intervention: Control
Only data collection was carried out.
No attempt was made by the researcher during the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Positive and Negative Syndrome Scale (PANSS)
Time Frame: 9 month
|
The PANNS scale provides an assessment of the severity of psychotic symptoms.
Data is collected by the researcher through a semi-structured interview with the patients.
In the scale consisting of 30 spiritual parameters; seven of them belong to the positive symptoms subscale, seven to the negative symptoms subscale, and the remaining sixteen to the general psychopathology subscale.
The total score varies between 30-210.
A total score of 58-74 from the scale is defined as mild, 75-94 points as moderate, 95-115 points as marked disease, and 116 and above points as severe disease.
|
9 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Functioning Assessment Scale
Time Frame: 9 month
|
It is a 19-item Likert-type scale developed for schizophrenia patients.
Each item is in the range of 1-3 points.
It is seen that the scale consists of four factors as interpersonal relations and entertainment, self-care, independent living skills and working life.
The score that can be obtained from the scale is in the range of 19-57, and a high score from the scale means that the individual has a high level of social functionality.
|
9 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Duygu ÖZER, MsN, Saglik Bilimleri Universitesi
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SY200217B09
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychotic Disorders
-
Medical College of WisconsinCompletedSchizophrenia | Affective Disorders | Psychotic Disorder | Psychotic Mood Disorder
-
Søren Dinesen ØstergaardCompletedAffective Disorders, PsychoticDenmark
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
VA Office of Research and DevelopmentNot yet recruitingMI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMIHomelessness | Schizophrenia Spectrum Disorders | Psychotic Mood Disorders | Psychotic Affective Disorders | Ill-Housed PersonsUnited States
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Centre hospitalier de Ville-Evrard, FranceRecruiting
-
University Hospital, CaenRecruiting
-
University of MinnesotaUniversity of California, San FranciscoCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Cognitive Impairment | Psychosis | Treatment | Psychotic Depression | Psychotic Episode | Active Control | Psychotic Mood DisordersUnited States
-
University of California, San DiegoActive, not recruitingSchizophrenia | Schizoaffective Disorder | Mood Disorder, PsychoticUnited States
-
Boston Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical CenterCompletedPsychotic Disorders | Psychosis | Psychotic EpisodeUnited States
Clinical Trials on Acceptance and Commitment Therapy
-
Francisco Garcia TorresUniversidad de CórdobaRecruiting
-
Anne Roche, MACompletedQuality of Life | AgingUnited States
-
University of CoimbraUnknown
-
Universiti Sains MalaysiaRecruitingBreast Cancer FemaleMalaysia
-
University of CyprusNot yet recruitingDepression | Anxiety Disorders | Post Traumatic Stress Disorder
-
University of Alabama at BirminghamWithdrawn
-
Nova Scotia Health AuthorityCompleted
-
University of TromsoThe Royal Norwegian Ministry of HealthActive, not recruiting
-
VA Office of Research and DevelopmentCompletedChronic Pain | Mild Traumatic Brain Injury | Distress-based PsychopathologyUnited States
-
University of Alabama at BirminghamCompletedPsychological DistressUnited States